• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Poult Sci . Antiviral and immunomodulatory effects of Siji antiviral mixture against H9N2 avian influenza virus infection in chickens

tetano

Editor, Senior Moderator
Poult Sci


. 2026 Jun 24;105(10):107336.
doi: 10.1016/j.psj.2026.107336. Online ahead of print.
Antiviral and immunomodulatory effects of Siji antiviral mixture against H9N2 avian influenza virus infection in chickens

Yanjiao Liang[SUP] 1 [/SUP], Jingting Yang[SUP] 1 [/SUP], Changmao Jian[SUP] 1 [/SUP], Miaoxiang Zhang[SUP] 1 [/SUP], Kewei Chen[SUP] 1 [/SUP], Junwei Yang[SUP] 1 [/SUP], Ping Luo[SUP] 1 [/SUP], Meilan Mo[SUP] 1 [/SUP], Tianchao Wei[SUP] 1 [/SUP], Teng Huang[SUP] 1 [/SUP], Jianni Huang[SUP] 2 [/SUP]


Affiliations
Free article Abstract

The H9N2 subtype avian influenza virus (AIV) is common in poultry and poses significant risks to both the poultry industry and public health. Current control strategies for H9N2 AIV predominantly rely on vaccination; however, these approaches are often undermined by the continuous antigenic drift of hemagglutinin under the pressure of antibodies. This study evaluated the antiviral efficacy of Siji Antiviral Mixture (SAM) against H9N2 infection in specific pathogen-free chickens. Compared with the infected control group, SAM significantly reduced viral loads in multiple tissues, including liver, spleen, lung, kidney, brain, and trachea, demonstrating its direct antiviral activity. Further analysis revealed that SAM modulated H9N2-induced inflammation by downregulating excessive innate immune responses. Specifically, SAM significantly enhanced the expression of antiviral effectors (OASL and MX-1) in the lungs during the early stages of viral infection, while attenuating the production of inflammatory cytokines (IL-6, IL-10) in the later stages. Additionally, SAM regulated the expression levels of pattern recognition receptors (MDA5, TLR3, and TLR7), thereby preventing excessive immune responses. These findings indicate that SAM possesses both antiviral and immunoregulatory effects, highlighting its potential as an effective anti-AIV agent for the management of H9N2 AIV infection.

Keywords: Antiviral; H9N2 avian influenza virus; Inflammation; Replication; Siji antiviral mixture.

 
Back
Top